2014
DOI: 10.1016/j.carres.2013.10.011
|View full text |Cite
|
Sign up to set email alerts
|

Shaping up for structural glycomics: a predictive protocol for oligosaccharide conformational analysis applied to N-linked glycans

Abstract: Graphical abstract

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

9
44
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 23 publications
(53 citation statements)
references
References 58 publications
9
44
0
Order By: Relevance
“…However, the data suggest that 100 ns MD simulation is far too short to sample the conformational space of the glycosidic linkage sufficiently when an oligomer is simulated by such a canonical MD, while the microsecond‐scale MD simulation succeeded in sampling the minima obtained by the PMF calculations. This is in agreement with the previous observations about the timescales for rigorous sampling of oligosaccharides by the MD approach . The minima of the PMFs determined by umbrella‐sampling simulations agree well with the data obtained for heparin in microsecond‐scale MD simulations and from the experiment (PDB ID: 1HPN) .…”
Section: Resultssupporting
confidence: 91%
See 1 more Smart Citation
“…However, the data suggest that 100 ns MD simulation is far too short to sample the conformational space of the glycosidic linkage sufficiently when an oligomer is simulated by such a canonical MD, while the microsecond‐scale MD simulation succeeded in sampling the minima obtained by the PMF calculations. This is in agreement with the previous observations about the timescales for rigorous sampling of oligosaccharides by the MD approach . The minima of the PMFs determined by umbrella‐sampling simulations agree well with the data obtained for heparin in microsecond‐scale MD simulations and from the experiment (PDB ID: 1HPN) .…”
Section: Resultssupporting
confidence: 91%
“…This is in agreement with the previous observations about the timescales for rigorous sampling of oligosaccharides by the MD approach. [41,42] The minima of the PMFs determined by umbrella-sampling simulations agree well with the data obtained for heparin in microsecond-scale MD simulations [16] and from the experiment (PDB ID: 1HPN). [43] For GlcNS(6S)-IdoA(2S), two minima corresponding to (ϕ, ψ) values near (−70, −120) and (−100, 60), respectively, were obtained.…”
Section: Contact Potentials From the Pdbsupporting
confidence: 72%
“…Polysaccharides are found throughout the biosphere, alone and also conjugated to other biopolymers such as proteins, in the form of glycoproteins, or to lipids in the form of glycolipids [140,141]. In comparison to nucleic acids and proteins, carbohydrates have larger capacity of complexity through the presence of numerous chiral centers within the sugar/ monosacchride subunits, the greater possible combinations of glycosidic linkages between different carbons within the sugar subunits resulting in branching, and to modifications to individual sugar subunits such as acetylation, methylation, oxidation, and sulfation [139,142].…”
Section: Imaging Of Biopolymersmentioning
confidence: 99%
“…Also on the topic of bacterial membranes, Kong et al [50] studied the multi-microsecond dynamics of export through the Wza transporter of K30 oligosaccharides (part of bacteria's protective layer) of various lengths. Sattelle et al [51] used multi-microsecond simulations to study the dynamics of oligosaccharides in water, modeled in the GLYCAM force field [52].…”
Section: Conformational Rearrangements and Unstructured Proteinsmentioning
confidence: 99%
“…It is thanks to extensive and detailed refinements in force fields conducted in the last decades, and still ongoing, that we can extract kinetic information and extrapolate timescales even for conformations outside of the typical "stability basins" of backbones and side chains. Force-fields are still ongoing refinements, and this is especially important because they are now covering nonprotein macromolecules, as we have seen in the review: small molecules [59], lipids [58], and proteoglycans [51], ions, etc.…”
Section: Past Present and Future Challenges Of MDmentioning
confidence: 99%